Acquisitions in the Life Sciences Start-Up Space: A Principal-Agent Problem in the Making
Acquisitions in the Life Sciences Start-Up Space: A Principal-Agent Problem [...]
Progress Report: Canada’s Gilead of the North
Progress Report: Canada’s Gilead of the North By Roberto Bellini [...]
Digital Innovation in Canada
Digital Innovation in Canada Are you prepared to capitalize on [...]
Guest Editorial- Keeping your business investor friendly
If someone asks you how your business is doing, you [...]
Guest Editorial
Canada continues to be one of the world’s leaders in [...]
Cross-Border Mergers and Acquisitions – 5 Tips for a Successful Deal
As the world becomes one giant global marketplace, it is [...]
Focusing on Fundamentals in a Hot Biotech Market: How Management and Bankers Can Help
I appreciate the chance to contribute to Brian and Jolyon’s [...]
Canada Will Have a Gilead of the North Within 10 Years
Many in our industry remember the golden era during [...]
The Tragedy in the Commercialization of Canadian Life Sciences Discoveries
“Australia excels in biomedical research but sucks at commercialisation.” [...]
Jason Donville at the Bloom Burton & Co. Healthcare Investor Conference
Jason Donville at the Bloom Burton & Co. Healthcare Investor Conference
By Jason Donville| May 6th, 2016|Blog, Commentary, Guest Editorial|
The Donville Kent (DKAM) investment team recently attended the Bloom [...]